Rotator Cuff Injury Treatment Market Size and Share Analysis by Treatment (Surgical Treatment, Physiotherapy, Pharmaceutical Treatment), Injury Severity (Full-Thickness, Partial-Thickness), Cause (Acute, Degenerative), End User (Hospitals, Specialty clinics) - Global Industry Revenue Estimation and Demand Forecast to 2030

Market Overview

The global rotator cuff injury treatment market revenue stood at USD 1,098.4 million in 2022, which is expected to observe a CAGR of 5.1% during 2022–2030, to reach USD 1,633.5 million.

This can be attributed to the surging incidence of shoulder injuries due to sports, technological enhancements in arthroscopic surgery devices, and increasing osteoarthritis problem in the geriatric population.

Sports and physical activities can cause high physical stress on the shoulder, leading to rotator cuff tendonitis, which causes pain and weakness in the shoulder, thus limiting the movement of the arm. Athletes engaged in sports such as baseball, handball, tennis, and volleyball regularly fall on their shoulders. Additionally, with the increasing number of vehicles on the road, the frequency of traffic accidents is rising, many of which result in injury to the rotator cuff.

Moreover, over the next few years, there would be an increase in the demand for minimally invasive surgical devices on account of the rising demand for minimally invasive operations. Additionally, rising in the expansion of research & development efforts and launch of the efficient therapies during the projected period leads to rise in the market for treating rotator cuff injuries. The market for treating rotator cuff injuries will expand at an even faster rate in the future due to the large unmet need for current treatments and advancements in medical technology.

Surgical Treatment Is Expected To Hold Largest Share

The surgical treatment category accounted for the largest revenue share, around 55%, in 2022, and it is further expected to maintain its dominance during the forecast period. This is owing to the high incidence of rotator cuff injuries and the favorable medical reimbursement for their treatment.

Moreover, the growing awareness of the benefits of an arthroscopic repair, including its low risk of complications, quick recovery, and low incidence of post-operative infections, is expected to significantly contribute to the category’s growth.

Furthermore, medical device companies are actively involved in the development of advanced surgical solutions for rotator cuff injury treatment. For instance, in July 2021, Stryker InSpace launched a subacromial balloon space, which provides comfort to patients suffering from severe rotator cuff tears.

Additionally, the physiotherapy category will have significant growth during the forecast period. This is credited to the fact that athletes often use this as the first approach for the management of such injuries. Additionally, the increase in the geriatric population is a major factor helping in the growth of this category, as aged people prefer this treatment over surgical procedures.

The pharmaceutical drugs category is also expected to record healthy growth in the market. The easy availability of medications, such as non-steroidal anti-inflammatory drugs and steroids, plays important role in making the treatment of rotator cuff injuries accessible and cost-effective.

Frequency of Sports-Related Shoulder Injuries Is Increasing

The increasing number of sports injuries is the major factor augmenting the market growth. Around 3.5 million sports-related injuries occur every year in the U.S. Additionally, three-quarters of all sports injuries happen in the upper extremities. Tennis, Baseball, handball, and volleyball players remain at an omnipresent risk of physical trauma due to falls, arm stretching, and other events. Such incidents can cause shoulder injuries, including rotator cuff contusions, worsen the existing injuries, or also result in the development of tendinopathy in rotator cuff tears.

Partial-Thickness Category Dominates Market

The partial-thickness category accounted for the larger revenue share, over 60%, in 2022, and it is further expected to maintain its position during the forecast period. This is ascribed to the fact that the chances of abnormalities, such as osteoarthritis or bone injuries, increase with age, and they may be traumatic for athletes, especially if caused by an injury.

However, most commonly, partial-thickness tears are seen in people over the age of 50, and they may be chronic or related to minor trauma. As per a study published by the National Library of Medicine, the problem may have a greater scale than reported originally, as the identification of intra-tendinous lesions, which result in over half of the cases of partial-thickness defects, has been difficult.

Degenerative Category To Show Faster Growth

The degenerative category will witness the faster growth during the prediction period, with a CAGR of more than 6%. This will be owing to the fact that the poor vascularity of the rotator crescent is directly linked to age. As people age, the rotator cuff can undergo degenerative changes, which often results in shoulder dysfunction. A degenerative cuff tear may not be immediately problematic, owing to its gradual onset and often undetectable nature.

Many people with a degenerative tear can function normally. Moreover, 20–40% of the people aged 61–69 suffer from these tears, but feel no noticeable weakness or pain. Tears are known to progress from tendinopathy first to partial-thickness tears and, then, to full-thickness tears, with time. Prospective research has challenged Earlier hypotheses that such problems originate at the anterior supraspinatus tendon insertion, which is adjacent to the bicep tendon.

New Orthobiologics Are Being Developed

Regenerative biologics are a fast-expanding technology that has the potential to profoundly alter sports orthopedics. Despite the advent of sophisticated sutures, the high failure rates have led many researchers to choose biological therapy to speed up the healing of a wound. Numerous manufacturers, including Smith+Nephew, Zimmer, Johnson & Johnson (through its DePuy Division), and Stryker, are intensifying their efforts to diversify their product offerings in this market. In addition, the emergence of numerous new companies creating novel regenerative biologics is going to lead to potentially effective cures for rotator cuff problems.

For instance, in March 2020, in a critical preclinical trial, ORTHO-R biopolymer, developed by Ortho Regenerative Technologies Inc., yielded positive results. This chitosan-based biopolymer matrix is a mucoadhesive that serves as a biodegradable scaffold. It is combined with the platelet-rich plasm of patients to create biologics, which further helps increase the healing rate of tendon injuries. With orthobiologics continuing to be advanced, invasive orthopedic surgeries will likely transition to a minimally invasive technique.

Explore more about this report - Request free sample pages

North America Is Prime Revenue Contributor

North America captured the largest revenue share in the market, of around 45%, in 2022. This is attributed to the ongoing R&D, rising count of product launches, and commercialization of innovative treatments for rotator cuff injuries. Moreover, the increasing funding and count of partnerships among major companies, favorable regulatory environment for rotator cuff surgeries, as well as the supportive government policies for the sale of associated goods boost the market. Moreover, the substantial engagement in sports will allow the region to maintain its dominance during the forecast period.

The American Academy of Orthopedic Surgeons (AAOS) estimates that every year, almost 2 million Americans seek medical attention for rotator cuff problems. The market growth is also projected to be aided by the expanding use of bracing devices for pre- and post-operative patient care, as well as the presence of multiple large manufacturers of orthobiologic products.

Moreover, companies in the region are focusing on the development of innovative and advanced products. For instance, in August 2021, Johnson & Johnson (DePuy Synthes) introduced INHANCE, a fully integrated shoulder arthroplasty system. Similarly, in September 2020, Smith & Nephew announced the launch of HEALICOIL knotless suture for use during the arthroscopic treatment of a rotator cuff rupture.

In addition, companies are showing interest in merging with and demerging from each other, to increase their sports medicine offerings, including surgical products for rotator cuff tear treatment. For example, in March 2019, Stryker declared the acquisition of Israel-based organization OrthoSpace.

Moreover, Europe will show significant growth in this market, with the advancement of the healthcare infrastructure and favorable policies for reimbursement for rotator cuff illness treatment. In addition, this region has built new infrastructure for sports, which, in turn, could drive the incidence of shoulder injuries and have a positive impact on this sector.

Furthermore, Germany is showing significant growth in Europe region. This is owing due to the rise of healthcare budget in the country, adopting technology-based solutions, growing sports facilities in the region, rising awareness by the government to the patients for early diagnosis of disease and effective treatment, reimbursement policies by government and healthcare personals are rapidly adopting the technology for early detection and accurate results are the key factor dominate the market expansion.

Top Providers of Rotator Cuff Injury Treatment Solution Are:

• GlaxoSmithKline plc
• Johnson & Johnson 
• Boehringer Ingelheim International GmbH
• Sanofi
• AstraZeneca plc
• Smith & Nephew plc
• Integra LifeSciences Holding Corporation
• CONMED Corporation
• Arthrex Inc.
• 3S ORTHO

Market Size Breakdown by Segment

The study uncovers the biggest trends and opportunities in the market, along with offering segmentation analysis at the granular level for the period 2017 to 2030.

Based on Treatment

• Surgical Treatment
  •  Arthroscopy (tendon repair)
  • Traditional/open surgery
    • Shoulder replacement surgery
    • Open tendon repair or transfer
• Physiotherapy
  • Orthopedic braces
  • Cold compression therapy
• Pharmaceutical Treatment

Based on Injury Severity

• Full-Thickness
• Partial-Thickness

Based on Cause

• Acute
• Degenerative
  • Repetitive stress
  • Lack of blood supply
  • Bone spurs 

Based on End User

• Hospitals
• Specialty clinics
• Others

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe Rotator
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • U.A.E.